PATENT CLAIM ANALYSIS

Application Number: 15781303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "210160"]

Abstract:
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Claim (Index 11):
The assay of  claim 10 , wherein HTT is total HTT and the capture/detection antibody pair is MAB2166/#5656S; and, wherein HTT is mutant HTT and the capture/detection antibody pair is MW1/#5656S.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 2.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14160180', '14242282', '13812366', '13653192', '14363051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7748723004048079
- 35 USC 102 Novelty (BERT): 0.5351316266102596
- Combined Prediction Score: 0.7508982330253531
- Mean Citation Score: 296.341898
- Max Citation Score: 358.8583
- Similarity Product: 190.5796880236983

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test